Thailand Pharma and Healthcare Sector Report 2026-2027
An EMIS Insights Industry ReportEMIS is an ISI Markets Company Date: January 2026
Pages: 44
Available in: English
Thailand's pharmaceutical and healthcare industry has experienced substantial growth over the past few decades. In 2002, the Thai government launched a successful initiative to establish universal healthcare for all Thai citizens, guaranteeing coverage for over 99.9% of the population. Thailand is also a globally recognised medical hub, with more Joint Commission International-accredited hospitals than any other ASEAN country. Thailand continues to face significant disparities in healthcare coverage despite these notable achievements. The healthcare system's disproportionate focus on curative care, combined with Thailand's rapidly ageing population and the rising prevalence of non-communicable diseases (NCDs), has led to spiralling healthcare costs. Thailand's medical device and pharmaceutical manufacturers also focus on lower-value-added product segments, such as medical consumables and generic medications, thereby keeping the country's healthcare system dependent on imports. The government has implemented financial incentives to encourage companies to invest in developing domestic medical device and pharmaceutical manufacturing capabilities, as the COVID-19 pandemic highlighted the dangers of continued reliance on imports.
This report provides a complete and detailed analysis of the "Healthcare and pharma" sector for Thailand. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.
What this report allows you to do:
This report provides a complete and detailed analysis of the "Healthcare and pharma" sector for Thailand. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.
What this report allows you to do:
- Understand the key elements at play in the "Healthcare and pharma" sector in Thailand
- Crystallise the forces both driving and restraining this sector in Thailand
- Ascertain Thailand’s position in the global sector
- Build a complete perspective on sector trade, investment and employment
- Understand the competitive landscape and who the major players are
- View M&A activity and major deals
- Gain an understanding of the regulatory environment for the sector in Thailand.
- Build a clear picture of trends, output and consumption for specific sub-sectors
Have a question?
Email us at: emisstoresupport@isimarkets.com